TAILORx

TAILORx: an update incl 12-year event rates in woman with ER+ lymph node-negative breast cancer

Racial disparities in breast cancer and metastasis and possible contributing biological factors

Molecular profiling in early breast cancer

Should chemotherapy be used in post-menopausal patients with low genomic risk HR+ breast cancer?

Systemic therapy at the St Gallen Consensus: multi-gene testing, Ki67, and oligometastatic disease

Time for change: introducing genomic predictors in ER+ breast cancer

Genomic predictors for treatment selection in ER+ breast cancer: TAILORx, MINDACT, and RxPONDER

SABCS 2020: monarchE, PENELOPE-B, TAILORx & ASCENT

Trial updates in breast cancer from ASCO: TAILORx, PAKT, MONARCH 2 & MONALEESA-3

Breast cancer: new advances in personalized medicine and therapeutics